Apyx Medical (APYX) Cash from Investing Activities Growth (1y) (2012 - 2026)
Powered by 
Analysis
Apyx Medical (APYX) Cash from Investing Activities Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 0.00% |
| 10 | Apyx Medical | 128.92 Mn | 101.30 Mn | 8.87 Mn | 75.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.09% |
| Mar 31, 2026 | -9.09% |
| Dec 31, 2025 | -12.24% |
| Sep 30, 2025 | -239.22% |
| Jun 30, 2025 | 8.30% |
| Mar 31, 2025 | -57.14% |
| Dec 31, 2024 | -163.44% |
| Sep 30, 2024 | 12.07% |
| Jun 30, 2024 | -104.06% |
| Mar 31, 2024 | 68.18% |
| Dec 31, 2023 | 34.51% |
| Sep 30, 2023 | 7.45% |
| Jun 30, 2023 | 1,873.32% |
| Mar 31, 2023 | 60.57% |
| Dec 31, 2022 | 57.23% |
| Sep 30, 2022 | -10.59% |
| Jun 30, 2022 | -1,282.76% |
| Mar 31, 2022 | -45.31% |
| Dec 31, 2021 | 14.43% |
| Sep 30, 2021 | -1,788.89% |